Named on one round in the feed.
Since 2026-10-06
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
RougeTx A provider of first-in-class disease-modifying therapies designed to restore vascular integrity | Series A Verified against 4 of 6 sources | $58M | 2026-10-06 | [ PART ] |